Form 4: Intevac Director Ryan L. Vardeman Acquires Shares and Options

Sentiment:

SEC Form 4 Filing


Director Ryan L. Vardeman acquired 12,000 restricted stock units and 10,300 non-qualified stock options in Intevac Inc.

Summary

  • Ryan L. Vardeman, a director at Intevac Inc., has reported acquiring 12,000 restricted stock units, which will vest on May 15, 2025.
  • He also acquired 10,300 non-qualified stock options with an exercise price of $2.55, exercisable on May 15, 2025, and expiring on November 21, 2031.
  • These transactions were reported on November 14, 2024, and the earliest transaction date was November 12, 2024.
  • Mr. Vardeman also indirectly owns 1,053,924 shares through Palogic Value Fund, L.P., Palogic Value Management, L.P., and Palogic Capital Management, LLC.
  • He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The document is a routine filing and does not indicate any significant positive or negative sentiment. It reflects standard insider transactions.

Positives

  • The acquisition of shares and options by a director could be seen as a positive sign of confidence in the company's future.

Risks

  • The document does not explicitly state any risks, but the indirect ownership structure and disclaimers could be complex.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders reporting changes in their beneficial ownership of company securities. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

  • SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
  • The reporting of stock options and restricted stock units is common for executive compensation.
  • The indirect ownership structure through investment funds is also a common practice for directors and officers.

Stakeholder Impact

  • The transactions may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

DateDescription
11/12/2024Date of the earliest transaction.
11/14/2024Date the form was signed.
05/15/2025Vesting date for the restricted stock units and exercisable date for the stock options.
11/21/2031Expiration date for the stock options.

Keywords

Intevac, Director, Ryan L. Vardeman, Stock Options, Restricted Stock Units, Beneficial Ownership, Palogic Value Fund, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.